Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 6,165 | 3,261 | 10,813 | 23,003 | 4,790 |
| Cost of Goods | 2,590 | 2,130 | 3,055 | N/A | 2,081 |
| Gross Profit | 3,575 | 1,131 | 7,758 | 23,003 | 2,709 |
| Operating Expenses | 31,815 | 32,568 | 31,658 | 27,475 | 30,701 |
| Operating Income | -27,650 | -31,307 | -23,845 | -4,472 | -27,911 |
| Other Income | 985 | 968 | 665 | 266 | 162 |
| Pre-tax Income | -26,665 | -30,339 | -23,180 | -4,206 | -27,749 |
| Net Income Continuous | -26,665 | -30,339 | -23,180 | -4,206 | -27,749 |
| Net Income | $-26,665 | $-30,339 | $-23,180 | $-4,206 | $-27,749 |
| EPS Basic Total Ops | -17.65 | -20.27 | -15.49 | -2.88 | -18.73 |
| EPS Basic Continuous Ops | -17.83 | -20.31 | -15.54 | -2.83 | -18.68 |
| EPS Diluted Total Ops | -17.65 | -20.27 | -15.49 | -2.88 | -18.73 |
| EPS Diluted Continuous Ops | -17.83 | -20.31 | -15.54 | -2.83 | -18.68 |
| EBITDA(a) | $-27,311 | $-31,113 | $-23,456 | $-3,820 | $-27,212 |